|
Atrial Fibrillation
|
|
| |
|
| Medical Condition: |
Atrial Fibrillation |
| Facility / Clinic: |
Richmond, VA |
| Age: |
21+ |
| Gender: |
Male/Female |
| Brief Summary: |
Atrial fibrillation (AF) is an abnormal heart rhythm that results in irregular heart beats. Patients with AF have a higher risk of having a stroke and other blood clot complications. For this reason, patients with AF are often given a blood-thinning drug, such as Warfarin, to reduce the risk of forming a clot. Unfortunately, treatment with warfarin requires the patient to frequently monitor a blood test to make sure they don’t run the risk of bleeding. A phase III study is being conducted to compare the use of Warfarin (the standard) with a new, investigational blood thinning medication that is more easily managed and does not require frequent blood testing. |
| Key Inclusion / Exclusion Criteria: |
History of Atrial Fibrillation within the last 12 months
Expect to continue on blood thinning medication for the next 12 months
|
| Enrollment: |
Open |
| Patient Commitment Duration: |
13 months |
| Patient Compensation: |
You may be reimbursed up to $450 for your participation. |
| Number of Visits in Study: |
16 |
|
